NALEYA: APOE Alzheimer Test
Understand Alzheimer’s risk through genotype information.
APOE genotyping uses MALDI-TOF MS to help assess Alzheimer’s risk. Results should be interpreted alongside clinical information and family history; this test is not a diagnosis.
What Does the Test Check?
Genotipe APOE
Identifies APOE genetic variants associated with Alzheimer’s risk.
Alzheimer’s Risk
Helps assess genetic predisposition to Alzheimer’s disease.
Earlier Risk Detection
Provides genetic risk information before cognitive impairment develops.
Who Should Consider Testing?
Have a family history of Alzheimer’s disease.
Have cognitive impairment.
Have a high risk of Alzheimer’s disease.
Want to learn about their genetic risk related to brain health.
How Is the Sample Tested?
Blood Sample
The test uses a blood sample to analyze APOE genotype.
When Will the Report Be Available?
10 Business Days
after the sample is received by the laboratory
Learn About Your Alzheimer’s Risk Through Genetic Testing
Test Specifications
TechnologyMALDI-TOF Mass Spectrophotometry
SampleBlood ≥3 mL (Adults)
TAT10 Business Days